盈立盤前簡報(6.2) | 劉鶴與美財政部長視頻通話,科興疫苗獲世衛緊急使用授權,恆大物業股東擬套現
【隔夜美股覆盤】
①三大指數接近平收:道指漲0.13%、標普500跌0.05%、納指跌0.09%。週二公佈的製造業數據好於預期,但就業指數卻表現疲軟,本週五美國將公佈關鍵的月度就業報告。
②聯儲觀點:美聯儲理事佈雷納德週二表示目前的貨幣政策存在"雙邊風險",即經濟復甦帶動通脹上行的同時,勞動力市場仍處於遠遠落後的狀態。
③行業:油氣鑽井、熱煤、鈾、充電樁、鋼鐵、WSB概念、NFT概念領漲,AMC院線漲超22%;大麻股、醫療設備、太陽能、醫藥製造領跌。
④大宗商品:油價週二上漲,結算價創下逾兩年高位,因OPEC+預測全球原油市場供應趨緊;金價三天來首次下跌,因債券收益率升高;銅價下跌,鎳基本持平;跟蹤六種基本金屬的LME指數下跌0.1%。
⑤中概股:金龍中國指數上漲3.8%,收於5月初以來最高水平。科網股、教育股、電商股大漲,樂信漲超28%,荔枝漲超13%,拼多多漲超11%,蔚來漲超9%,新東方漲超8%,小鵬汽車、晶科能源、寶尊電商漲超7%,京東、嗶哩嗶哩漲近6%。
【今日港股前瞻】
①南方A50(2822 HK):中美全面經濟對話中方牽頭人劉鶴與美財政部長耶倫視頻通話,雙方認爲中美經濟關係十分重要。
②券商股: 證券時報頭版評論,證券研究預測指數點位不可隨意。
③內房股:央行公佈反洗錢法修訂草案徵求意見稿,擬將房地產開發商、貴金屬交易商等納入反洗錢調查範圍。
④石油股:WTI原油期貨創2018年10月以來高位,因OPEC+預測全球油市趨緊。
⑤中國生物製藥(1177 HK):科興疫苗獲世衛緊急使用授權,列入"緊急使用清單"。
⑥復星醫藥 (2196 HK): 香港預計可於短期內就降低復必泰疫苗接種年齡的申請作出決定。
⑦恆大物業(6666 HK):尋求以每股9.8港元的價格出售2.7億股,籌資3.41億美元。
⑧海普瑞(9989 HK):子公司收到藥物臨牀試驗補充申請批準。
⑨美團-W(3690 HK):花旗稱,美團管理層預計美團優選虧損或在夏季擴大,總虧損將於今年見頂。
⑩鳳凰衛視(2008 HK):信德集團擬斥5.16億收購鳳凰衛視約16.93%股權。
【IPO追蹤】
①時代天使更新聆訊後版本招股書。
②中國石墨集團港股遞表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.